🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate t...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-08
Trial ID
NCT07587242
This Phase 2 study (EPIMODE) will evaluate the efficacy and safety of CS1 c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07761572
The investigators developed a dual-target CAR-T targeting CD38 and CS1. Pre...
Status
Active Not Recruiting
Location
Second Hospital of Shandong University
Start Date
2024-04-30
Trial ID
NCT06574958
Treatments Being Tested
This trial is conducted to evaluate the safety and technical effectiveness ...
Status
Completed
Location
Kobe City General Hospital
Start Date
2016-05
Trial ID
NCT02907229
Treatments Being Tested
CS1-004 will be an extension of the CS1-003 Study. The primary objective of...
Status
No Longer Available
Location
Fredrik Frick
Start Date
TBD
Trial ID
NCT06321705
Treatments Being Tested
SAD study: Eighteen subjects will be included in the SAD study (single dos...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2017-10-06
Trial ID
NCT03903302
Treatments Being Tested
This phase I trial studies the side effects and best dose of CS1-chimeric a...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2019-04-23
Trial ID
NCT03710421
Treatments Being Tested
This is a Phase 2, parallel group study to evaluate the safety, tolerabilit...
Status
Completed
Location
Fredrik Frick
Start Date
2022-05-05
Trial ID
NCT05224531
Treatments Being Tested
The purpose of this study is to understand the safety and estimate the effi...
Status
Withdrawn
Location
Ashley Donihee
Start Date
2023-08
Trial ID
NCT04864522
Treatments Being Tested
This phase I trial studies the side effects and how well CART-BCMA/CS1 work...
Status
Withdrawn
Location
Melanie Ayala Ceja
Start Date
2024-03-28
Trial ID
NCT05950113